Barbara Kosacz

CIK 1763316 · COO & General Counsel · last filed 2026-05-26

Barbara Kosacz is a COO & General Counsel who has filed 25 SEC Form 4 insider transactions across 8 companies since 2019. The most recent filing, for XOMAP, was dated May 26, 2026. Across all open-market trades the lifetime net is +$87.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $243.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$243.4K

Companies

8

Total Filings

25

Lifetime Open-Market Net

$87.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XOMAP Director 9,557 $25.46 $243.4K $0 7 2026-05-26
LONA Director $8.35 $0 1 2026-04-13
LeonaBio, Inc. (ATHA) Delisted Director $6.92 $0 5 2025-06-03
CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Director 5,828 $0.05 $292 $0 1 2024-02-16
Kronos Bio, Inc. (KRON) Delisted COO & General Counsel 928,966 $0.88 $817.5K $87.1K 6 2024-01-05
CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted Director $10.37 $0 1 2021-10-12
LWACU Director $10.30 $0 1 2021-01-14
XOMA Director $41.79 $0 3 2020-05-27

Recent Filings

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-05-26 XOMAP Grant (A) +3,586 $0 EDGAR
2026-04-13 LONA Grant (A) $0 EDGAR
2025-06-03 LeonaBio, Inc. (ATHA) Delisted Grant (A) $0 EDGAR
2025-05-23 XOMAP Grant (A) +5,971 $0 EDGAR
2025-05-23 XOMAP Grant (A) +5,971 $0 EDGAR
2024-05-24 LeonaBio, Inc. (ATHA) Delisted Grant (A) $0 EDGAR
2024-05-17 XOMAP Grant (A) $0 EDGAR
2024-02-16 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Other (J) +5,828 $0 EDGAR
2024-01-05 Kronos Bio, Inc. (KRON) Delisted Sell (S) −10,676 -$12.6K EDGAR
2023-05-22 LeonaBio, Inc. (ATHA) Delisted Grant (A) $0 EDGAR
Showing 110 of 25
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.